Biotech

All Articles

Lilly, Haya ink $1B biobuck being overweight contract to browse black genome

.Eli Lilly's hunt for being overweight targets has led it to the darker genome. The Big Pharma has p...

ArsenalBio raises $325M, rotates away from previous lead asset

.Toolbox Biosciences is actually carrying on up. The cell treatment business has actually added on $...

Lilly- backed weight-loss biotech files IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has actually...

Aelis' marijuana make use of medicine fails period 2b, driving Indivior to reconsider $100M alternative

.Aelis Farma's chances of securing a quick, beneficial selection on a $100 million choice remittance...

ProKidney stops phase 3 test certainly not needed to have for tissue treatment approval

.ProKidney has quit some of a pair of period 3 trials for its cell therapy for kidney condition afte...

Vaxcyte climbs on 'stunning' 31-valent PCV win against Pfizer

.Vaxcyte introduced what experts named "sensational" stage 1/2 information for its 31-valent pneumoc...

Recursion's human brain ailment trial reveals scant evidence of effectiveness

.Recursion has actually stumbled through a very early examination of its own tech-enabled approach t...

Acepodia, Pfizer click with each other for chemistry-based cell treatment

.Contact it a scenario of excellent chemistry: Acepodia, a biotech based upon Nobel Champion science...

Praxis epilepsy medicine lessens seizures in phase 2 litigation

.Practice Preciseness Medicines has racked up an additional midphase gain in epilepsy this year, wit...

Three directors resign as Dyne posts blended data for DMD prospect

.After running away a professional hold a number of years back, Dyne Therapy has revealed brand-new ...